- |||||||||| Trial completion, Phase classification, Enrollment change: Treatment for Word Retrieval Impairments in Aphasia (clinicaltrials.gov) - Apr 7, 2018
P=N/A, N=24, Completed, Recruiting --> Completed | Phase classification: P2 --> PN/A Recruiting --> Completed | Phase classification: P1 --> PN/A | N=16 --> 24
- |||||||||| Phase classification, Enrollment change: Living With Frontotemporal Dementia (clinicaltrials.gov) - Apr 6, 2018
P, N=16, Terminated, Recruiting --> Completed | Phase classification: P1 --> PN/A | N=16 --> 24 Phase classification: P=N/A --> P | N=40 --> 16
- |||||||||| Enrollment change, Trial primary completion date: Computerised Therapy in Chronic Stroke (clinicaltrials.gov) - Jan 10, 2018
P=N/A, N=7, Completed, Active, not recruiting --> Completed N=40 --> 7 | Trial primary completion date: Jan 2015 --> May 2015
- |||||||||| Trial completion, Enrollment change: Cognitive Therapy to Improve Word Finding (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=78, Completed, Recruiting --> Completed Recruiting --> Completed | N=40 --> 78
- |||||||||| Zolinza (vorinostat) / Merck (MSD)
Trial completion, Enrollment change, Trial primary completion date: Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 (clinicaltrials.gov) - Dec 15, 2016 P1/2, N=12, Completed, Recruiting --> Completed | N=80 --> 16 | Trial primary completion date: Dec 2016 --> Aug 2016 Recruiting --> Completed | N=15 --> 12 | Trial primary completion date: Jun 2017 --> Dec 2016
- |||||||||| davunetide intranasal (AL-108) / Endo
Trial primary completion date: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Dec 7, 2016 P2, N=12, Active, not recruiting, Recruiting --> Completed | N=15 --> 12 | Trial primary completion date: Jun 2017 --> Dec 2016 Trial primary completion date: Jul 2016 --> Jul 2017
- |||||||||| Enrollment closed, Trial primary completion date: Brain Mechanisms Underlying Reading Improvement in Central Alexia (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=23, Active, not recruiting, Trial primary completion date: Feb 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jul 2016
- |||||||||| Trial primary completion date: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - Mar 21, 2016
P=N/A, N=16, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jul 2016 Trial primary completion date: Aug 2016 --> Dec 2016
- |||||||||| Trial termination: Living With Frontotemporal Dementia (clinicaltrials.gov) - Feb 29, 2016
P=N/A, N=40, Terminated, Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Terminated
- |||||||||| Trial completion, Enrollment change, Trial primary completion date, HEOR: Posterior Fossa Mutism on Quality of Life (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=24, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Completed | N=60 --> 24 | Trial primary completion date: Mar 2015 --> Mar 2012
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=3, Active, not recruiting, Recruiting --> Completed | N=60 --> 24 | Trial primary completion date: Mar 2015 --> Mar 2012 Recruiting --> Active, not recruiting | N=12 --> 3 | Trial primary completion date: Nov 2015 --> Nov 2016
- |||||||||| davunetide intranasal (AL-108) / Endo
Trial primary completion date: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Jan 28, 2016 P2, N=12, Active, not recruiting, Recruiting --> Active, not recruiting | N=12 --> 3 | Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Dec 2015 --> Jul 2016
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: A Composite MR Neuroimaging Marker for Alzheimer's Disease (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=0, Withdrawn, Trial primary completion date: Dec 2015 --> Jul 2016 N=380 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Mar 2014 --> Jan 2016
- |||||||||| Phase classification: PiB PET Scanning in Speech and Language Based Dementias (clinicaltrials.gov) - Dec 23, 2015
P1, N=168, Completed, N=380 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Mar 2014 --> Jan 2016 Phase classification: P=N/A --> P1
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Living With Aphasia: An International Study (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=15, Terminated, Active, not recruiting --> Enrolling by invitation N=204 --> 15 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> May 2012; Funding stopped
|